propafenone has been researched along with Pregnancy in 10 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
Excerpt | Relevance | Reference |
---|---|---|
"Propafenone is a potent antiarrhythmic agent effective in either supraventricular or ventricular tachyarrhythmias." | 8.79 | Propafenone in the treatment of cardiac arrhythmias. A risk-benefit appraisal. ( Boriani, G; Capucci, A, 1995) |
"Propafenone is a well-known Class 1C antiarrhythmic agent that has sodium channel blocking properties as well as the ability to block 13 other channels and a modest calcium antagonistic effect." | 5.72 | Effect of Rythmol (propafenone HCl) administration during pregnancy in Wistar rats. ( Abd-Allah, ER; Amin, S; Badawy, MA; El Ghareeb, AEW, 2022) |
"Propafenone is a potent antiarrhythmic agent effective in either supraventricular or ventricular tachyarrhythmias." | 4.79 | Propafenone in the treatment of cardiac arrhythmias. A risk-benefit appraisal. ( Boriani, G; Capucci, A, 1995) |
"Evaluation revealed mitral valve prolapse with minimal mitral regurgitation, and normal left ventricular size and function." | 1.28 | New onset ventricular tachycardia during pregnancy. ( Braverman, AC; Bromley, BS; Rutherford, JD, 1991) |
"In cases of non-immune hydrops fetalis caused by tachyarrhythmias, the transplacental passage of antiarrhythmic drugs may be hampered." | 1.27 | Direct intrauterine fetal treatment of fetal tachyarrhythmia with severe hydrops fetalis by antiarrhythmic drugs. ( Bald, R; Gembruch, U; Hansmann, M, 1988) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (30.00) | 18.7374 |
1990's | 3 (30.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 4 (40.00) | 2.80 |
Authors | Studies |
---|---|
Abd-Allah, ER | 1 |
Amin, S | 1 |
El Ghareeb, AEW | 1 |
Badawy, MA | 1 |
Basza, M | 1 |
Maciejewski, C | 1 |
Bojanowicz, W | 1 |
Balsam, P | 1 |
Grabowski, M | 1 |
Mitkowski, P | 1 |
Kempa, M | 1 |
Kowalski, O | 1 |
Kalarus, Z | 1 |
Jaguszewski, M | 1 |
Lubiński, A | 1 |
Daniłowicz-Szymanowicz, L | 1 |
Szumowski, Ł | 1 |
Sterliński, M | 1 |
Kołtowski, Ł | 1 |
Moon, JH | 1 |
Kim, YG | 1 |
Kim, K | 1 |
Osonoi, S | 1 |
Wang, S | 1 |
Saunders, DC | 1 |
Wang, J | 1 |
Yang, K | 1 |
Kim, H | 2 |
Lee, J | 1 |
Jeong, JS | 1 |
Banerjee, RR | 1 |
Kim, SK | 1 |
Wu, Y | 1 |
Mizukami, H | 1 |
Powers, AC | 1 |
German, MS | 1 |
Bjeloševič, M | 1 |
Illíková, V | 1 |
Tomko, J | 1 |
Olejník, P | 1 |
Chalupka, M | 1 |
Hatala, R | 1 |
Capucci, A | 1 |
Boriani, G | 1 |
Braverman, AC | 1 |
Bromley, BS | 1 |
Rutherford, JD | 1 |
Libardoni, M | 1 |
Piovan, D | 1 |
Busato, E | 1 |
Padrini, R | 1 |
Gembruch, U | 1 |
Hansmann, M | 1 |
Bald, R | 1 |
Brunozzi, LT | 1 |
Meniconi, L | 1 |
Chiocchi, P | 1 |
Liberati, R | 1 |
Zuanetti, G | 1 |
Latini, R | 1 |
Santinelli, V | 1 |
de Paola, M | 1 |
Turco, P | 1 |
Smimmo, D | 1 |
Chiariello, M | 1 |
Condorelli, M | 1 |
2 reviews available for propafenone and Pregnancy
Article | Year |
---|---|
Flecainide in clinical practice.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Child; Female; Flecainide; Humans; Pregnancy; Propafeno | 2023 |
Propafenone in the treatment of cardiac arrhythmias. A risk-benefit appraisal.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Electrophysiology; Female; | 1995 |
8 other studies available for propafenone and Pregnancy
Article | Year |
---|---|
Effect of Rythmol (propafenone HCl) administration during pregnancy in Wistar rats.
Topics: Animals; Anti-Arrhythmia Agents; Female; Humans; Placenta; Pregnancy; Propafenone; Rats; Rats, Wista | 2022 |
Serotonin Regulates Adult β-Cell Mass by Stimulating Perinatal β-Cell Proliferation.
Topics: Animals; Animals, Newborn; Cell Proliferation; Female; Glucose; Growth Hormone; Humans; Infant; Insu | 2020 |
Supraventricular tachyarrhythmias during the intrauterine, neonatal, and infant period: A 10-year population-based study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Incidence; Infant; Infant, Newborn; Male; Pregna | 2020 |
New onset ventricular tachycardia during pregnancy.
Topics: Adult; Electrocardiography; Electrophysiology; Female; Humans; Mitral Valve Insufficiency; Mitral Va | 1991 |
Transfer of propafenone and 5-OH-propafenone to foetal plasma and maternal milk.
Topics: Adult; Animals; Female; Fetal Blood; Humans; Maternal-Fetal Exchange; Milk; Pregnancy; Propafenone | 1991 |
Direct intrauterine fetal treatment of fetal tachyarrhythmia with severe hydrops fetalis by antiarrhythmic drugs.
Topics: Anti-Arrhythmia Agents; Female; Fetal Diseases; Flecainide; Humans; Hydrops Fetalis; Medigoxin; Preg | 1988 |
Propafenone in the treatment of chronic ventricular arrhythmias in a pregnant patient.
Topics: Adult; Arrhythmias, Cardiac; Female; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Pro | 1988 |
Wolff-Parkinson-White at risk and propafenone.
Topics: Administration, Oral; Adult; Female; Humans; Pregnancy; Propafenone; Wolff-Parkinson-White Syndrome | 1988 |